Clinical Trial Update: A Clinical Study to Assess the Safety and Pharmacokinetics of SRT2104 in Normal Healthy Male Volunteers [Phase 1]

View source ↗

Summary

Phase 1 safety and pharmacokinetics study of SRT2104 in healthy male volunteers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• SRT2104 (SRT2104)

Snippet

Sponsor: Sirtris, a GSK Company | Conditions: Diabetes Mellitus, Type 2, Healthy Volunteer | Phase 1 | Status: COMPLETED